Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Article

Majmaah J Heal Sci. 2013; 1(2): 7-13


Reliability of INFANIB among Normal and High Risk Term Neonates: A Cross Sectional Study

MY Wong, Sai L Ganesan, UV Shenoy, Jaya S Tedla, VS Binu.

Abstract
Background: Infant Neurological International Battery (INFANIB) is one of the common neurological assessment used for the infants. The reliability in the newborns is more essential to prove because INFANIB is used to predict the infant motor capabilities at later stages.

Objective: Objective of the study is to establish intra-rater and inter-rater reliability of Infant Neurological International Battery between normal and high risk term neonates.

Methods: In this cross sectional study a convenience sample of term neonates was included. Demographic data were completed from medical records. Rater one administered INFANIB on all the neonates and the assessments were being videotaped. The videos were anonymized and were viewed by two independent raters so they were blinded from knowing the groups from which each neonate belonged to. Rater three viewed 50 videos randomly for assessment of intra-rater agreement after one month. All the raters were blinded from scores of one another as well to avoid bias during assessment. For intra- as well as inter-rater reliability, two-way mixed, absolute agreement and single measure ICC was calculated.

Results: 112 neonates (normal=56; high risk=56) with mean (SD) gestational age of 39.1 (1.1) and 38.9 (1.1) weeks respectively on mean post natal day of 4 were assessed. For intra-rater agreement the ICC was 0.42 (0.05-0.7) for normal neonates and 0.33 (0-0.63) for high risk neonates. For inter-rater agreement the ICC was 0.1 (0-0.26) for normal neonates and 0.28 (0.05-0.5) for high risk neonates.

Conclusion: The intra-rater and inter-rater reliability of INFANIB proved to be poor between the normal and high risk term neonates. Formal training should be given to any profession or health workers who are planning to use INFANIB as a screening tool for early neurodevelopmental delay among neonates to improve the inter-rater agreement.

Key words: Neonatology, Neurodevelopment, Reliability, INFANIB, Screening



Similar Articles

Clinical Evaluation of the Rapid STANDARD Q COVID-19 Ag Test for the Screening of Severe Acute Respiratory Syndrome Coronavirus 2.
Kim HW, Park M, Lee JH
Annals of laboratory medicine. 2022; 42(1): 100-104

Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening.
Yoon S, Moon HW, Kim H, Hur M, Yun YM
Annals of laboratory medicine. 2022; 42(1): 63-70

The Discovery of Peptide Macrocycle Rescuers of Pathogenic Protein Misfolding and Aggregation by Integrating SICLOPPS Technology and Ultrahigh-Throughput Screening in Bacteria.
Delivoria DC, Skretas G
Methods in molecular biology (Clifton, N.J.). 2022; 2371(): 215-246

3D and 4D Tumorigenesis Model for the Quantitative Analysis of Cancer Cell Behavior and Screening for Anticancer Drugs.
Wessels D, Lusche DF, Voss E, Soll DR
Methods in molecular biology (Clifton, N.J.). 2022; 2364(): 299-318

RNAi Feeding Bioassay: A Protocol for dsRNA Screening Against Asian Citrus Psyllid and Related Hemipteran Insects.
Dos Santos Silva J, de Santana Cerqueira LR, Hunter WB, de Andrade EC
Methods in molecular biology (Clifton, N.J.). 2022; 2360(): 85-90


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites